HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

B-Cell Prolymphocytic Leukemia

A neoplasm of prolymphocytes affecting the blood, bone marrow, and spleen. It is characterized by prolymphocytes exceeding 55% of the lymphoid cells in the blood and profound splenomegaly.
Also Known As:
Leukemia, Prolymphocytic, B-Cell; B Cell Prolymphocytic Leukemia; B-Cell Prolymphocytic Leukemias; Leukemia, B-Cell Prolymphocytic; Leukemias, B-Cell Prolymphocytic; Prolymphocytic Leukemia, B-Cell; Prolymphocytic Leukemias, B-Cell
Networked: 40 relevant articles (8 outcomes, 2 trials/studies)

Relationship Network

Disease Context: Research Results

Related Diseases

1. B-Cell Chronic Lymphocytic Leukemia (Chronic Lymphocytic Leukemia)
2. Hairy Cell Leukemia
3. Lymphoma (Lymphomas)
4. Lymphoproliferative Disorders (Lymphoproliferative Disorder)
5. Neoplasms (Cancer)

Experts

1. He, Qiang: 1 article (01/2022)
2. Li, Zengjun: 1 article (01/2022)
3. Wang, Hui: 1 article (01/2022)
4. Xie, Linna: 1 article (01/2022)
5. Xing, Lijie: 1 article (01/2022)
6. Borthakur, Gautam: 1 article (01/2021)
7. Ferrajoli, Alessandra: 1 article (01/2021)
8. Price, Allyson: 1 article (01/2021)
9. Siddiqui, Maria Tariq: 1 article (01/2021)
10. Nohgawa, Masaharu: 1 article (10/2020)

Drugs and Biologics

Drugs and Important Biological Agents (IBA) related to B-Cell Prolymphocytic Leukemia:
1. Rituximab (Mabthera)FDA Link
2. ibrutinibIBA
3. venetoclaxIBA
4. Phosphotransferases (Kinase)IBA
5. Chlorambucil (Leukeran)FDA Link
6. Lenalidomide (CC 5013)FDA Link
7. idelalisibIBA
8. obinutuzumabIBA
9. zanubrutinibIBA
10. CD18 AntigensIBA

Therapies and Procedures

1. Therapeutics
2. Hematopoietic Stem Cell Transplantation
3. Splenectomy
4. Drug Therapy (Chemotherapy)
5. Peripheral Blood Stem Cell Transplantation (Peripheral Stem Cell Transplantation)